Alpha-synuclein repeat variants and survival in parkinson's disease

Movement Disorders

Volumn 29, Issue 8, 2014, Pages 1053-1057

  Chung, Sun Ju ^a   Biernacka, Joanna M ^b   Armasu, Sebastian M ^b   Anderson, Kari ^b   Frigerio, Roberta ^c   Aasly, Jan O ^d   Annesi, Grazia ^e   Bentivoglio, Anna Rita ^f   Brighina, Laura ^g   Chartier Harlin, Marie Christine ^h,i   Goldwurm, Stefano ^j   Hadjigeorgiou, Georgios ^k   Jasinska Myga, Barbara ^l,m   Jeon, Beom Seok ⁿ   Kim, Yun Joong ^o   Krüger, Rejko ^p   Lesage, Suzanne ^q   Markopoulou, Katerina ^c   Mellick, George ^r   Morrison, Karen E ^s   Puschmann, Andreas ^t   Tan, Eng King ^u   Crosiers, David ^v,w,x   Theuns, Jessie ^v,w   Van Broeckhoven, Christine ^v,w   Wirdefeldt, Karin ^y   Wszolek, Zbigniew K ^m   Elbaz, Alexis ^z   Maraganore, Demetrius ^c   Yahalom, Gilad ^aa   Orlev, Yael ^aa   Cohen, Oren S ^aa   Kozlova, Evgenia ^aa   Friedman, Eitan ^aa,ab   Inzelberg, Rivka ^aa   Hassin Baer, Sharon ^aa   more..

^a University of Ulsan College of Medicine   (South Korea)

^b MAYO CLINIC   (United States)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

^g SAN GERARDO HOSPITAL   (Italy)

^h INSERM   (France)

ⁱ UNIV LILLE   (France)

^j PARKINSON INSTITUTE   (Italy)

^k UNIVERSITY OF THESSALY   (Greece)

^l MEDICAL UNIVERSITY OF SILESIA   (Poland)

^m MAYO CLINIC   (United States)

ⁿ Seoul National University Hospital   (South Korea)

^o Hallym University   (South Korea)

^p UNIVERSITY OF TÜBINGEN   (Germany)

^q SORBONNE UNIVERSITÉ   (France)

^r GRIFFITH UNIVERSITY   (Australia)

^s UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^t LUND UNIVERSITY   (Sweden)

^u SINGAPORE GENERAL HOSPITAL   (Singapore)

^v DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^w UNIVERSITY OF ANTWERP   (Belgium)

^x ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^y KAROLINSKA INSTITUTE   (Sweden)

^z CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^aa TEL AVIV UNIVERSITY   (Israel)

^ab SHEBA MEDICAL CENTER   (Israel)

more..

Author keywords

Association; Gene; Parkinson's disease; Survival; synuclein

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; CLINICAL TRIAL; DINUCLEOTIDE REPEAT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; ONSET AGE; PARKINSON DISEASE; SURVIVAL; VERY ELDERLY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; DINUCLEOTIDE REPEATS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; PARKINSON DISEASE; SURVIVAL;

EID: 84904431856     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25841     Document Type: Article

References (28)

1. Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998;18:106-108.
2. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
3. Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004;55:164-173.
4. Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003;302:841.
5. Cronin KD, Ge D, Manninger P, et al. Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain. Hum Mol Genet 2009;18:3274-3285.
6. Fuchs J, Tichopad A, Golub Y, et al. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. FASEB J 2008;22:1327-1334.
7. Maraganore DM, de Andrade M, Elbaz A, et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 2006;296:661-670.
8. Chiba-Falek O, Nussbaum RL. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mol Genet 2001;10:3101-3109.
9. Chiba-Falek O, Touchman JW, Nussbaum RL. Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene. Hum Genet 2003;113:426-431.
10. Bonsch D, Lederer T, Reulbach U, Hothorn T, Kornhuber J, Bleich S. Joint analysis of the NACP-REP1 marker within the alpha synuclein gene concludes association with alcohol dependence. Hum Mol Genet 2005;14:967-971.
11. Linnertz C, Saucier L, Ge D, et al. Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues. PLoS One 2009;16:e7480.
12. Lewis J, Melrose H, Bumcrot D, et al. In vivo silencing of alpha-synuclein using naked siRNA. Mol Neurodegener 2008;3:19.
13. McCormack AL, Mak SK, Henderson JM, Bumcrot D, Farrer MJ, Di Monte DA. Alpha-synuclein suppression by targeted small interfering RNA in the primate substantia nigra. PLoS One 2010;5:e12122.
14. Schneeberger A, Mandler M, Mattner F, Schmidt W. Vaccination for Parkinson's disease. Parkinsonism Relat Disord 2012;18:S11-S113.
15. Chung SJ, Armasu SM, Biernacka JM, et al. Genomic determinants of motor and cognitive outcomes in Parkinson's disease. Parkinsonism Relat Disord 2012;18:881-886.
16. Ritz B, Rhodes SL, Bordelon Y, Bronstein J. alpha-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease. PLoS One 2012;7:e36199.
17. Brighina L, Frigerio R, Schneider NK, et al. Alpha-synuclein, pesticides, and Parkinson disease: a case-control study. Neurology 2008;70:1461-1469.
18. Chung SJ, Armasu SM, Biernacka JM, et al. Common variants in PARK loci and related genes and Parkinson's disease. Mov Disord 2011;26:280-288.
19. Therneau TM, Grambsch PM, Fleming TR. Martingale-based residuals for survival models. Biometrika 1990;77:147-160.
20. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-526.
21. Lumley T. rmeta: meta-analysis. R package, version 2.16. 2009. Available at: http://CRAN.R-project.org/package=rmeta, Accessed November 15, 2011.
22. David C. Modelling Survival Data in Medical Research. London: Chapman & Hall/CRC; 1999.
23. Hadjigeorgiou GM, Xiromerisiou G, Gourbali V, et al. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset. Mov Disord 2006;21:534-539.
24. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-639.
25. Mondragon-Rodriguez S, Basurto-Islas G, Lee HG, et al. Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis. Expert Rev Neurother 2010;10:683-691.
26. Muenter MD, Forno LS, Hornykiewicz O, et al. Hereditary form of parkinsonism-dementia. Ann Neurol 1998;43:768-781.
27. Farrer M, Kachergus J, Forno L, et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 2004;55:174-179.
28. Elbaz A, Bower JH, Peterson BJ, et al. Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol 2003;60:91-96.